The U.S. Food and Drug Administration has granted OmniActive Health Technologies GRAS (generally regarded as safe) clearance for the use of Lutemax Free Lutein in infant formula. The company, which ...

A new eyedrop has shown early success in delivering protective compounds to where they’re needed most in the eye, raising hopes for less invasive treatment of serious vision conditions. The research ...

You have full access to this article via your institution. We hypothesize that lutein is more likely to have an effect on severe retinopathy. The pathogenesis of ROP is hypoxic ischemic injury to the ...